These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8089500

  • 1. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
    Ferraresso M, Tian L, Ghobrial R, Stepkowski SM, Kahan BD.
    J Immunol; 1994 Oct 01; 153(7):3307-18. PubMed ID: 8089500
    [Abstract] [Full Text] [Related]

  • 2. Kinetics of in vitro immune responses of T and B cells during tolerance induction by sirolimus.
    Ghobrial R, Karczewski M, Ferraresso M, Tian L, Stepkowski SM, Kahan BD.
    Ann Transplant; 1996 Oct 01; 1(4):22-9. PubMed ID: 9869901
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
    Ferraresso M, Ghobrial R, Stepkowski SM, Kahan BD.
    Transplantation; 1993 Apr 01; 55(4):888-94. PubMed ID: 8475565
    [Abstract] [Full Text] [Related]

  • 4. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Padberg W, Uhteg LC, Ma L, Lord RH, Araneda D, Strom TB, Diamantstein T, Tilney NL.
    Eur J Immunol; 1987 Mar 01; 17(3):313-9. PubMed ID: 2952511
    [Abstract] [Full Text] [Related]

  • 5. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ, Schwartz CF, Lin H, Chen GH, Bolling SF.
    J Surg Res; 1999 Feb 01; 81(2):123-8. PubMed ID: 9927530
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ, Hancock WW, Schmidbauer G, Corpier CL, Wieder I, Kobzik L, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1993 Jul 15; 151(2):1158-66. PubMed ID: 8335897
    [Abstract] [Full Text] [Related]

  • 7. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
    Wasowska B, Wieder KJ, Hancock WW, Zheng XX, Berse B, Binder J, Strom TB, Kupiec-Weglinski JW.
    J Immunol; 1996 Jan 01; 156(1):395-404. PubMed ID: 8598490
    [Abstract] [Full Text] [Related]

  • 8. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
    Kupiec-Weglinski JW, Wasowska B, Papp I, Schmidbauer G, Sayegh MH, Baldwin WM, Wieder KJ, Hancock WW.
    J Immunol; 1993 Nov 01; 151(9):5053-61. PubMed ID: 8409456
    [Abstract] [Full Text] [Related]

  • 9. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y, Tang XD, Zhou PJ.
    Scand J Immunol; 2005 Mar 01; 61(3):266-73. PubMed ID: 15787744
    [Abstract] [Full Text] [Related]

  • 10. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
    Wang ME, Stepkowski SM, Ferraresso M, Kahan BD.
    Transplantation; 1992 Oct 01; 54(4):704-9. PubMed ID: 1412762
    [Abstract] [Full Text] [Related]

  • 11. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Vallera DA.
    J Immunol; 1998 Jun 01; 160(11):5355-65. PubMed ID: 9605135
    [Abstract] [Full Text] [Related]

  • 12. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
    Chen H, Wu J, Xu D, Luo H, Daloze PM.
    Transplantation; 1993 Sep 01; 56(3):661-6. PubMed ID: 8212164
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Persistent infiltration of CD45RC- CD4+ T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion.
    Miyanari N, Yamaguchi Y, Matsuno K, Tominaga A, Goto M, Ichiguchi O, Mori K, Ogawa M.
    Hepatology; 1997 Apr 01; 25(4):1008-13. PubMed ID: 9096612
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T, Yang J, Dannowski H, Vogt K, Volk HD, Pleyer U.
    Transpl Immunol; 2007 Nov 01; 18(2):101-7. PubMed ID: 18005852
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K, Maki T, Wood ML, Monaco AP.
    Transplantation; 1995 Dec 15; 60(11):1268-73. PubMed ID: 8525521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.